AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
12th International Symposium of Radiopharmacology - Interlaken (Switzerland) June 12-15, 2001 - Foreword
Authors: Guilloteau, D Maziere, B Moretti, JL Grognet, JM de Beco, V
Citation: D. Guilloteau et al., 12th International Symposium of Radiopharmacology - Interlaken (Switzerland) June 12-15, 2001 - Foreword, Q J NUCL M, 45(2), 2001, pp. 123-123
Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands
Authors: Emond, P Helfenbein, J Chalon, S Garreau, L Vercouillie, J Frangin, Y Besnard, JC Guilloteau, D
Citation: P. Emond et al., Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands, BIO MED CH, 9(7), 2001, pp. 1849-1855
Plasma fatty acid levels in autistic children
Authors: Vancassel, S Durand, G Barthelemy, C Lejeune, B Martineau, J Guilloteau, D Andres, C Chalon, S
Citation: S. Vancassel et al., Plasma fatty acid levels in autistic children, PROS LEUK E, 65(1), 2001, pp. 1-7
D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT
Authors: Tranquart, F Saliba, E Barantin, L Lanneau, M Simmer, L Guilloteau, D Baulieu, JL
Citation: F. Tranquart et al., D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT, CLIN NUCL M, 26(1), 2001, pp. 36-40
Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET
Authors: Vercouillie, J Tarkiainen, S Halldin, C Emond, P Chalon, S Sandell, J Langer, O Guilloteau, D
Citation: J. Vercouillie et al., Precursor synthesis and radiolabelling of [C-11]ADAM: A potential radioligand for the serotonin transporter exploration by PET, J LABEL C R, 44(2), 2001, pp. 113-120
Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey
Authors: Bezard, E Boraud, T Chalon, S Brotchie, JM Guilloteau, D Gross, CE
Citation: E. Bezard et al., Pallidal border cells: An anatomical and electrophysiological study in the1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey, NEUROSCIENC, 103(1), 2001, pp. 117-123
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
Authors: Bezard, E Dovero, S Prunier, C Ravenscroft, P Chalon, S Guilloteau, D Crossman, AR Bioulac, B Brotchie, JM Gross, CE
Citation: E. Bezard et al., Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J NEUROSC, 21(17), 2001, pp. 6853-6861
Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases
Authors: Prunier, C Tranquart, F Cottier, JP Giraudeau, B Chalon, S Guilloteau, D De Toffol, B Chossat, F Autret, A Besnard, JC Baulieu, JL
Citation: C. Prunier et al., Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases, NUCL MED C, 22(11), 2001, pp. 1207-1214
Characterization of Tc-99m-DTPA aerosols for lung permeability studies
Authors: Diot, P Galinier, E Grimbert, D Bugeon, S Valat, C Lemarie, E Diot, E Baulieu, JL Besnard, JC Guilloteau, D
Citation: P. Diot et al., Characterization of Tc-99m-DTPA aerosols for lung permeability studies, RESPIRATION, 68(3), 2001, pp. 313-317
Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission
Authors: Chalon, S Vancassel, S Zimmer, L Guilloteau, D Durand, G
Citation: S. Chalon et al., Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission, LIPIDS, 36(9), 2001, pp. 937-944
MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain
Authors: Cantagrel, S Gressens, P Bodard, S Suc, AL Laugier, J Guilloteau, D Chalon, S
Citation: S. Cantagrel et al., MRNA D-2 dopaminergic receptor expression after hypoxia-ischemia in rat immature brain, BIOL NEONAT, 80(1), 2001, pp. 68-73
[I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors
Authors: Baulieu, JL Resche, I Bardies, M Chauvet, AF Lecloirec, J Malhaire, JP Thomas, E Faurous, P Sassolas, G Pourcelot, L Chatal, JF Guilloteau, D Besnard, JC
Citation: Jl. Baulieu et al., [I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors, NUCL MED BI, 27(8), 2000, pp. 809-813
Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET
Authors: Dolle, F Bottlaender, M Demphel, S Emond, P Fuseau, C Coulon, C Ottaviani, M Valette, H Loc'h, C Halldin, C Mauclaire, L Guilloteau, D Maziere, B Crouzel, C
Citation: F. Dolle et al., Highly efficient synthesis of [C-11]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET, J LABEL C R, 43(10), 2000, pp. 997-1004
Synthesis of [C-11]2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-methyl, -ethyland isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography
Authors: Sandell, J Halldin, C Helfenbein, J Chou, YH Vercouillie, J Emond, P Swahn, CG Guilloteau, D Farde, L
Citation: J. Sandell et al., Synthesis of [C-11]2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-methyl, -ethyland isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography, J LABEL C R, 43(10), 2000, pp. 1033-1046
Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide
Authors: Gouhier, C Chalon, S Venier-Julienne, MC Bodard, S Benoit, JP Besnard, JC Guilloteau, D
Citation: C. Gouhier et al., Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide, NEUROSCI L, 288(1), 2000, pp. 71-75
Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex
Authors: Zimmer, L Delpal, S Guilloteau, D Aioun, J Durand, G Chalon, S
Citation: L. Zimmer et al., Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex, NEUROSCI L, 284(1-2), 2000, pp. 25-28
Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains
Authors: Zimmer, L Kodas, E Guilloteau, D Garreau, L Besnard, JC Chalon, S
Citation: L. Zimmer et al., Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains, J NEUROSC M, 103(2), 2000, pp. 137-144
Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids
Authors: Zimmer, L Delion-Vancassel, S Durand, G Guilloteau, D Bodard, S Besnard, JC Chalon, S
Citation: L. Zimmer et al., Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J LIPID RES, 41(1), 2000, pp. 32-40
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I
Authors: Hall, H Halldin, C Guilloteau, D Chalon, S Emond, P Besnard, JC Farde, L Sedvall, G
Citation: H. Hall et al., Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I, NEUROIMAGE, 9(1), 1999, pp. 108-116
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter
Authors: Helfenbein, J Sandell, J Halldin, C Chalon, S Emond, P Okubo, Y Chou, YH Frangin, Y Douziech, L Gareau, L Swahn, CG Besnard, JC Farde, L Guilloteau, D
Citation: J. Helfenbein et al., PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter, NUCL MED BI, 26(5), 1999, pp. 491-499
Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease
Authors: Chalon, S Emond, P Bodard, S Vilar, MP Thiercelin, C Besnard, JC Guilloteau, D
Citation: S. Chalon et al., Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease, SYNAPSE, 31(2), 1999, pp. 134-139
Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach
Authors: Collet, C Lecomte, P Guilloteau, D Lejeune, B Lecomte, C Besnard, JC
Citation: C. Collet et al., Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach, EUR J ENDOC, 141(3), 1999, pp. 225-230
Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET.
Authors: Helfenbein, J Emond, P Loc'h, C Bottlaender, M Ottaviani, M Guilloteau, D Maziere, B Frangin, Y Chalon, S
Citation: J. Helfenbein et al., Synthesis of (E)-N-(3-bromoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(4 '-tolyl) nortropane (PE2Br) and radiolabelling of [Br-76]PE2Br: A potential ligand for exploration of the dopamine transporter by PET., J LABEL C R, 42(6), 1999, pp. 581-588
Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.
Authors: Helfenbein, J Emond, P Sandell, J Halldin, C Pereyre, S Frangin, Y Garreau, L Besnard, JC Guilloteau, D Chalon, S
Citation: J. Helfenbein et al., Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET., J LABEL C R, 42(4), 1999, pp. 337-347
Dopamine D-2 receptor brain imaging in the neonatal period using I-123-IBZM SPECT
Authors: Tranquart, F Saliba, E Zimmer, L Barantin, L Lanneau, M Guilloteau, D Baulieu, JL
Citation: F. Tranquart et al., Dopamine D-2 receptor brain imaging in the neonatal period using I-123-IBZM SPECT, J NUCL MED, 40(12), 1999, pp. 2126-2127
Risultati: 1-25 | 26-30